File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.14447/jnmes.v25i4.a02
- Scopus: eid_2-s2.0-85146320921
- WOS: WOS:000913381900002
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A DFT study of Graphene as a drug carrier for gemcitabine anticancer drug
| Title | A DFT study of Graphene as a drug carrier for gemcitabine anticancer drug |
|---|---|
| Authors | |
| Keywords | density functional theory drug delivery gemcitabine graphene |
| Issue Date | 31-Dec-2022 |
| Publisher | Journal of New Materials for Electrochemical Systems; 1999 |
| Citation | Journal of New Materials for Electrochemical Systems, 2022, v. 25, n. 4, p. 234-239 How to Cite? |
| Abstract | Research is being carried out worldwide for possible treatment of cancer. Graphene has been studied as a drug carrier for various cancer-related drugs [1-2]. In the present work, we apply theoretical models to study the electrons interactions, thermodynamic properties, and solvent interaction of the drug-carrier configuration. The stability of graphene means that it can be a nanocarrier in the biological system. The simulations result shows that graphene provides a stable base, where gemcitabine is a highly dissolvable and reactive drug. The adsorption of gemcitabine on the graphene was physical. The drug carrier configuration formed a highly impactful drug-carrier design. |
| Persistent Identifier | http://hdl.handle.net/10722/338883 |
| ISSN | 2023 Impact Factor: 0.7 2023 SCImago Journal Rankings: 0.230 |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Abahussain, AAM | - |
| dc.contributor.author | Zaidi, SZJ | - |
| dc.contributor.author | Nazir, MH | - |
| dc.contributor.author | Raza, M | - |
| dc.contributor.author | Nazir, MH | - |
| dc.contributor.author | Hassan, S | - |
| dc.date.accessioned | 2024-03-11T10:32:14Z | - |
| dc.date.available | 2024-03-11T10:32:14Z | - |
| dc.date.issued | 2022-12-31 | - |
| dc.identifier.citation | Journal of New Materials for Electrochemical Systems, 2022, v. 25, n. 4, p. 234-239 | - |
| dc.identifier.issn | 1480-2422 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/338883 | - |
| dc.description.abstract | <p>Research is being carried out worldwide for possible treatment of cancer. Graphene has been studied as a drug carrier for various cancer-related drugs [1-2]. In the present work, we apply theoretical models to study the electrons interactions, thermodynamic properties, and solvent interaction of the drug-carrier configuration. The stability of graphene means that it can be a nanocarrier in the biological system. The simulations result shows that graphene provides a stable base, where gemcitabine is a highly dissolvable and reactive drug. The adsorption of gemcitabine on the graphene was physical. The drug carrier configuration formed a highly impactful drug-carrier design.</p> | - |
| dc.language | eng | - |
| dc.publisher | Journal of New Materials for Electrochemical Systems; 1999 | - |
| dc.relation.ispartof | Journal of New Materials for Electrochemical Systems | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | density functional theory | - |
| dc.subject | drug delivery | - |
| dc.subject | gemcitabine | - |
| dc.subject | graphene | - |
| dc.title | A DFT study of Graphene as a drug carrier for gemcitabine anticancer drug | - |
| dc.type | Article | - |
| dc.description.nature | link_to_OA_fulltext | - |
| dc.identifier.doi | 10.14447/jnmes.v25i4.a02 | - |
| dc.identifier.scopus | eid_2-s2.0-85146320921 | - |
| dc.identifier.volume | 25 | - |
| dc.identifier.issue | 4 | - |
| dc.identifier.spage | 234 | - |
| dc.identifier.epage | 239 | - |
| dc.identifier.isi | WOS:000913381900002 | - |
| dc.identifier.issnl | 1480-2422 | - |